by St. Jude Children's Research Hospital | Jun 30, 2020 | Mobile Health, News, Oncology
An innovative, interactive cloud-based data portal debuted this week that lets academic researchers mine the world’s largest and most comprehensive collection of scientific resources for studying pediatric solid tumors and their related biology. The Childhood...
by Chinese Academy of Sciences | May 26, 2020 | News, Oncology
Developing safe and efficient bioformulations using approved materials and ingenious designs can accelerate the clinical translation process. Scientists from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have developed a new therapeutic...
by Melissa Moody-Penn | Apr 17, 2020 | News, Oncology
Researchers have shown they can modify a “PARP inhibitor” drug to boost its ability to kill cancer cells. The prospective PARP inhibitor drug has struggled to show effectiveness in clinical trials against cancers, but the modification could change that. The team also...
by Georgia State University | Feb 11, 2020 | News, Oncology
A new method to detect cancer in its early stages using a targeted MRI contrast agent that binds to proteins has been identified by a team of researchers led by Georgia State University Regents’ Professor Jenny Yang. In their study, published in the journal...
by University of New Mexico Health Sciences Center | Feb 10, 2020 | Oncology, News
Cervical cancer is the third most common cancer in women worldwide, but most American women can prevent it by being screened with tests that detect human papillomaviruses (HPV). A new study led by University of New Mexico Comprehensive Cancer Center scientists shows...
by medicalxpress | Jan 17, 2020 | News, Oncology
(HealthDay)—The U.S. Food and Drug Administration is adding to a list of recalled lots of popular heartburn medications—including generic forms of Zantac—because the pills might contain small amounts of a suspected carcinogen. The substance, called...
